Cytodyn Inc (CYDY) Return on Equity ROE from the fourth quarter 2026 to fourth quarter 2025 and annually, average high and low, overall ranking from May 31 2026 to May 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cytodyn inc   (CYDY)

Cytodyn Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Cytodyn Inc in the fourth quarter 2026?
Due to the lack of equity, it was not possible to calculate Cytodyn Inc 's return on equity (ROE) in its fourth quarter 2026

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (May 31 2026)
IV. Quarter		 (Feb 28 2026)
III. Quarter		 (Nov 30 2025)
II. Quarter		 (Aug 31 2025)
I. Quarter		 (May 31 2025)
IV. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -43 -39 -39 -21 4
Return On Equity (TTM) - - - - -
CYDY's Total Ranking # # # # #
Equity (TTM) in Millions -110 -104 -96 -100 -96
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to CYDY Management Effectiveness >> CYDY's 5 Years Annual ROE >> Compare CYDY ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





CYDY Annual Return On Equity (May 31 2026)
2026		 (May 31 2025)
2025		 (May 31 2024)
2024		 (May 31 2023)
2023		 (May 31 2022)
2022
Total Equity in Millions -110 -96 -117 -110 -94
Y / Y Equity Change - - - - -
Net Income in Millions -43 4 -50 -80 -211
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to CYDY Management Effectiveness >> CYDY's 5 Years Annual ROE >> Compare CYDY ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CYDY's' Return on Equity at Yahoo Finance
CYDY's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CYDY's Competitors
Subscribers only: Roe for Cytodyn Inc 's Suppliers
Subscribers only: Return On Equity for CYDY's Customers




Companies with similar Return On Equity at May 31 2026, within Healthcare Sector ROE
Medpace Holdings Inc   110.15 %
Pulmatrix Inc   108.83 %
Rigel Pharmaceuticals Inc  96.49 %
Exelixis Inc   93.62 %
Alnylam Pharmaceuticals Inc   93.61 %
Eli Lilly And Company  92.54 %
Arbutus Biopharma Corp  90.98 %
Amgen Inc   89.32 %
Q32 Bio Inc   76.88 %
3m Company  76.55 %
Oramed Pharmaceuticals Inc  73.03 %
Tg Therapeutics Inc   72.30 %
Idexx Laboratories Inc  71.96 %
Elite Pharmaceuticals Inc   71.10 %
Zoetis Inc   68.87 %
Rallybio Corporation  68.56 %
Earth Science Tech Inc   66.17 %
Aurinia Pharmaceuticals Inc   59.00 %
Vaxart Inc   53.04 %
Qhslab Inc   51.21 %
Tenet Healthcare Corp  50.64 %
Nrc Health  48.29 %
Concentra Group Holdings Parent Inc   48.13 %
Bristol myers Squibb Company  46.65 %
Agilent Technologies inc   41.99 %
Eton Pharmaceuticals Inc   40.13 %
Adma Biologics Inc   39.59 %
Dexcom Inc   36.25 %
Transmedics Group Inc   33.37 %
Arcutis Biotherapeutics Inc   32.92 %

Date modified: 2026-09-05T08:54:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.